causal
61
Pro
0
Against

Adding NAC to OCD medication doesn't seem to help kids and teens better control their obsessive thoughts compared to just taking the medication alone.

Scientific Claim

N-acetylcysteine (NAC) added to citalopram does not significantly improve resistance to obsessions in children and adolescents with OCD compared to placebo, with a mean change of 1.8 (2.3) in the NAC group versus 0.8 (2.1) in the placebo group (P=0.2).

Original Statement

The mean change of score of resistance/control to obsessions in the NAC and placebo groups was 1.8(2.3) and 0.8(2.1), respectively (P = 0.2).

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

probability

Can suggest probability/likelihood

Assessment Explanation

The study design supports causal inference, but the small sample size and high dropout rate limit precision. The study states 'no statistically significant decrease' but the evidence strength warrants 'may not significantly improve' to reflect uncertainty.

More Accurate Statement

N-acetylcysteine (NAC) added to citalopram may not significantly improve resistance to obsessions in children and adolescents with OCD compared to placebo, with a mean change of 1.8 (2.3) in the NAC group versus 0.8 (2.1) in the placebo group (P=0.2).

Evidence from Studies

Contradicting (0)

0
No contradicting evidence found